Accepted Articles                   Back to the articles list | Back to browse issues page

XML Print


1- Department of Emergency Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
2- Department of Emergency Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. , Vafadarme@mums.ac.ir
Abstract:   (52 Views)
Introduction: Lidocaine hydrochloride is an acetamide derivative that was first introduced by Nils Löfgrene during 1943.  It is a local anesthetic agent that is widely used in order to prepare patient for repairing lacerations in everyday practice. Neurological toxicities have been reported with systemic and topical lidocaine.
Case Presentation: An 8-year-old female child was reported with a pure laceration who developed status epilepticus after receiving lidocaine along with ketamine. The patient had no medical history of epilepsy or allergic reaction and had a normal physical and mental development status. She received 200 mg lidocaine without epinephrine and underwent wound repair. The patient also received 60 mg of intramuscular ketamine in order to produce a relative sedation. After an hour of wound repair, she developed a tonic-colonic generalized seizure representative of status epilepticus seizure. The convulsions were managed by benzodiazepines, the patient was discharged without complication.
Conclusion:  Status epilepticus can happen due to lidocaine. Although patients usually recover with no major complications, obeying safety protocols can prevent these events.
Full-Text [PDF 1301 kb]   (26 Downloads)    
Type of Study: Case & Review | Subject: Emergency Medicine
Received: 2021/05/13 | Accepted: 2019/07/19

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Journal of Pediatrics Review

Designed & Developed by : Yektaweb